ArticleEmerging microbes & infections2025
Unveiling the enterovirus diversity in Barcelona, Spain (2020-2024) through wastewater and clinical surveillance.
Article in Emerging microbes & infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Serotypes distribution characteristic of enterovirus in sewage in Hangzhou, Zhejiang Province from January 2023 to December 2024.Virology journal · 2026Article
- National Surveillance of Enterovirus D68 Upsurge, France, 2024.Emerging infectious diseases · 2026Article
- Advances in Antiviral Drug Development Targeting Enteroviruses: From Viral Proteins to Host Factors.Viruses · 2026Review
- Detection of echovirus 7 in effluent sewage treatment plant Ahvaz city, Iran.Iranian journal of microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enterovirus (EV) infections are common and often mild or asymptomatic but can occasionally cause serious illness in children. Routine clinical surveillance typically underestimates the full spectrum of circulating EVs, whereas wastewater-based epidemiology captures a broader viral diversity and may serve as an early warning tool. We conducted a 5-year surveillance (2020-2024) in Barcelona, Spain, combining biweekly wastewater sampling with clinical EV reporting during the SARS-CoV-2 pandemic and subsequent relaxation of restrictions. We quantified EV genome copies in sewage by RT-qPCR and performed partial VP1 sequencing on wastewater concentrates and on clinical specimens. Over the study period, wastewater EV loads broadly paralleled reported case trends, with good correlations over the years except in 2022. A monotonic relationship was observed for certain EV type trends, including CVA6, CVB2, CVB3, E11, and EV-D68, but there was low robustness in their predictive capacity for clinical cases. Overall, deep sequencing revealed 122 distinct EV types in wastewater versus 92 types in clinical samples; 66 types were found in both sources, whereas 56 types appeared only in sewage. Sequences from wastewater and clinical sources showed high genetic similarity. Dominant EV types shifted over time highlighting the virus dynamics. These findings demonstrate that integrating WS with clinical surveillance yields a more comprehensive picture of EV circulation, uncovering hidden viral diversity and enabling early detection of emerging public health threats.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.